Analytical Data
-
Gene name
KLHDC2
- Application
-
Alternative Names
HCA33
-
Species
Human
-
Source
Baculovirus
-
Tag
N-His;N-GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9Y2U9-1
-
Expression Region
M1-K362
-
Protein Length
Partial
-
Molecular Weight
69 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
KLHDC2, known as Kelch-like family member 2, is a protein belonging to the Kelch domain-containing protein family, which plays crucial roles in various biological processes, including cell signaling, cytoskeleton organization, and the regulation of the immune response. Research has indicated that KLHDC2 may be involved in the pathogenesis of certain diseases, particularly autoimmune disorders and cancers, where its expression levels can be altered. Understanding the structure and function of KLHDC2 is essential for elucidating its biological roles and potential as a therapeutic target. Recent studies have focused on the recombinant expression of KLHDC2 to investigate its molecular mechanisms and interactions with other proteins. By using recombinant DNA technology, researchers are able to produce large quantities of KLHDC2 in a controlled manner, allowing for detailed biochemical and biophysical analyses. These studies aim to characterize the protein’s functionality, assess its role in cellular processes, and explore its potential for use in diagnostics or therapeutics. This research is critical for advancing our understanding of KLHDC2’s contributions to health and disease, ultimately paving the way for novel treatment strategies targeting KLHDC2-related pathways.
